Pax Herbal Clinic and Research Laboratories in Edo State, says it has developed Pax CVD PUS for the treatment of the COVID-19 infection.
Fr Anslem Adodo OSB, the director of the clinic stated that plant-based drugs are supposedly the best approach for the Coronavirus disease considering that these drugs are easily produced, stored and distributed and can be handled by medical and non medical personnel as they pose low contamination risk.
He further stated that a new drug called the “CVD PLUS” solely for the treatment of the Coronavirus has been developed.
The constituents are antiviral and immunodulatory agents which help to stimulate antibodies.
He said that the Pax CVD PLUS contains herbs and active phytoconstituents with documented scientific evidence based on clinical reports of their efficacy and safety.
Fr. Anslem expressed gratitude to the Head of the National Institute of Pharmaceutical Research and Development, Professor Tunde Salako and the Director General of NAFDAC, Professor Catherine Adeyeye for interest, support and encouragement in the course of the research.
The official statement
The research, he stated, is a joint effort of experts from University of Lagos and University of Benin, a tertiary health institution—Irrua Specialist Teaching Hospital, Edo State and experts sent by Prof. Tunde Salako and Prof. Catherine Adeyeye.
Fr. Anselm assured the public that NAFDAC is ready to speed up approval of the CVD Plus and while that is ongoing, other approved products such as the Pax Herbal Bitters, Pax Herbal Bitter Tea and Pax Herbal Health Tea could be used to manage symptoms of the Coronavirus.
